In multiple sclerosis, an impairment of the glymphatic system may contribute to pathology accrual in the central nervous system and disability progression.
-
-
Research Highlights
Characterizing amyloid-positive individuals with persistent normal tau PET levels
Baseline characteristics of Aβ-positive individuals can help identify those who will remain tau-negative for at least 5 years. -
Greater diffusion restriction in the white matter of amyloid-beta-positive cognitively unimpaired individuals supports the role of inflammation in early preclinical AD.
-
Research Highlights
Effect of Intra-arterial Alteplase after Angiographically Successful Thrombectomy
New Neurology Update from Stroke Scientific Panel -
The revised Boston criteria allow for a more accurate diagnosis of cerebral amyloid angiopathy
-
Research Highlights
Whole genome sequencing for the diagnosis of neurological repeat expansion disorders
WGS can reliably assess the most common neurological disease-causing repeat expansions, further supporting its implementation in clinical practice. -
Research Highlights
How does palliative care help people with neurological disease and their caregivers?
New Neurology Update from Palliative Care is in! Read more about the topics here -
The EAN Guideline Production Group has developed a template for EAN guideline protocols, to facilitate production of high quality guidelines. -
Paper of the MonthEAN NewsFeatured SliderResearch Papers of the Month: ‘Trial of Cinpanemab in Early Parkinson’s Disease’ and ‘Trial of Prasinezumab in Early-Stage Parkinson’s Disease’
This month we have selected two phase-2 trials investigating α-synuclein-binding antibodies as potential disease-modifying treatment of Parkinson’s disease. -
Paper of the MonthEAN NewsCOVID-19Featured SliderCovid-19 Paper of the Month: Risk of SARS-CoV-2 infection, hospitalization, and death for COVID-19 in people with Parkinson disease or parkinsonism over a 15-month period
Our authors of the month for September conclude that people with Parkinson's Disease and parkinsonism showed a higher risk of SARS-CoV-2 infection throughout the first 15 months of the pandemic. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke
Our research paper of the month presents the results of the ‘SWIFT direct’ trial, a randomised, open-label, blinded-outcome trial, aiming to investigate whether thrombectomy alone would be non-inferior to thrombectomy plus intravenous alteplase in patients with acute ischaemic stroke due to anterior circulation large vessel occlusion. -
EAN NewsResearchCOVID-19Contribute to the EAN Neuro-Covid Registry (ENERGY) and be part of our growing global project
The EAN Neuro-covid ReGistrY has now collected over 3,400 cases from more than 40 centres all over the world. Get involved! -
EAN is happy to announce its second Science School, taking place in Salzburg, Austria, on 18-20 March, 2023. -
EAN NewsResearchInterviewsEur J NeurolVideo Interview: European Journal of Neurology Award winner, Dr. Jonathan Coutinho
Prof. Didier Leys, Editor-in-Chief of the European Jounal of Neurology, talks to the winner of the first EJoN prize, Dr. Jonathan Coutinho. -
EAN NewsResearchInnovative Health Initiative launches call featuring topic on neurodegenerative diseases
The Innovative Health Initiative, a public-private partnership between the European Union and the European life science industries, has launched its first call for proposals, including a topic focusing on neurodegenerative diseases.